Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma

Clinical trial NCT03374007 · UNKNOWN

Trial details

NCT number: NCT03374007
Sponsor: Genor Biopharma Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Recurrent Solid Tumor Lymphoma Recurrent Lymphocyte Depleted Classical Hodgkin Lymphoma

Start date: 2017-10-19
Primary completion: 2022-06-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.